Skip to content

News Category: Health & Medical

HealthBeats Raises US$3m Seed Funding Led By Heritas Capital And SEEDS Capital To Expand Remote Vitals Monitoring In Australia And Singapore

By asianet

HealthBeats(TM), a Singapore-based healthtech start-up with end-to-end remote vitals monitoring solution, today announced the close of a US$3m Seed round led by healthcare investor Heritas Capital together with SEEDS Capital, the investment arm of government agency Enterprise Singapore. The HealthBeats(TM) Remote Vitals Monitoring platform provides healthcare providers and patients with a simple-to-use and simple-to-deploy solution … Continued

Zimmer Biomet’s mymobility is recognized as “The Care Management Initiative of the Year” by the 2022 Healthcare Asia Medtech Awards

By asianet

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that the company’s mymobility(R) digital care management platform won “The Care Management Initiative of the Year” award at this year’s Healthcare Asia Medtech Awards. mymobility(R) is a digital care management platform that uses iPhone(R) and Apple Watch(R) or Android devices … Continued

Glooko Appoints Alfonso “Chito” Zulueta, former Eli Lilly & Company Senior Executive, to Board of Directors

By asianet

Glooko, Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the appointment of Alfonso “Chito” Zulueta to its Board of Directors. Logo – https://mma.prnewswire.com/media/1043398/Glooko_Logo.jpg Respected as a leader with a strong track record of success in the pharmaceutical industry and deep experience on corporate … Continued

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

By asianet

Direct Biologics ( https://c212.net/c/link/?t=0&l=en&o=3515622-1&h=961943011&u=https%3A%2F%2Fwww.directbiologics.com%2F&a=Direct+Biologics ), a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct Biologics is the first … Continued

Seegene unveils world’s first commercialized ‘3 Ct’ PCR assay

By asianet

-Provides Ct value of three targets in one channel; ‘3 Ct’ PCR assay to launch in H1 -“Dream MDx technology” developed based on Seegene’s 20-year expertise; combines 19 different patented technologies, including DPO(TM), TOCE(TM), MuDT(TM)-‘3 Ct’ to lay foundation for automated syndromic testing and make MDx more accessible Seegene Inc. (KQ096530), South Korea’s leading molecular … Continued

Novaliq Presents Data from Second Phase 3 Trial of Investigational Treatment Cyclasol(R) (0.1% Cyclosporine Ophthalmic Solution) at the American Society of Cataract and Refractive Surgery Annual Meeting

By asianet

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol(R) water-free technology, today announced that data from the second pivotal Phase 3 trial (ESSENCE-2) evaluating the investigational drug CyclASol(R) for the treatment of dry eye disease (DED), was presented as part of a podium symposium at the American Cataract … Continued

SonoScape S-Fetus 4.0 Release to Simplify Sonography Process

By asianet

SonoScape Medical Corp. today announced the release of S-Fetus 4.0, the latest software upgrade of the company’s flagship ultrasound product offering. This technical breakthrough marks S-Fetus 4.0 as the globally first smart obstetric screening technology based on deep learning. Leveraging the deep learning techniques, the S-Fetus 4.0 Obstetric Screening Assistant allows doctors to automatically acquire … Continued

The First International COVID-19 Testing Standard Released

By asianet

According to the State Administration for Market Regulation, the International Organization for Standardization (ISO) released the first international standard specifically for the detection of SARS-CoV-2, the virus that causes COVID-19. On April 19, ISO issued “ISO/TS 5798:2022 In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 … Continued

AI Medical Service Inc. Announces 8 Billion JPY (US$70 M) Series C Financing Led by SoftBank Vision Fund 2 (SVF2)

By asianet

– First Instance of SVF2 Investing in Japanese Medical AI Company – AI Medical Service Inc. (hereinafter AIM), the Tokyo-based med-tech company using deep learning technology to develop endoscopic AI, has announced 8 billion JPY (US$70 million) of financing led by SoftBank Vision Fund 2 (SVF2) and joined by existing investors Globis Capital Partners, World … Continued